%0 Journal Article
%T The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer
%A Katsuya Nagayama
%A Katsuyuki Takahashi
%A Mitsutaka Takada
%A Naruo Yoshimura
%A Ryo Inose
%A Tomoya Kawaguchi
%J Oncomedicine
%D 2018
%R 10.7150/oncm.21294
%X Purpose Adjuvant therapy with cisplatin and vinorelbine (CV therapy) is recommended for patients after complete surgical resection of stage II and IIIA non-small cell lung cancer (NSCLC). However, a dose reduction or early discontinuation of a subsequent course of treatment is a frequent clinical problem. The aim of this study was to investigate the factors reducing the relative dose intensity (RDI) of adjuvant CV therapy in patients with NSCLC.
%K adjuvant therapy
%K cisplatin
%K vinorelbine
%K non-small cell lung cancer.
%U http://www.oncm.org/v03p0009.htm